We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Worthington Biochemical Introduces AOF Collagenase/Neutral Protease Blends

Product News  
Published: September 24, 2014
 
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy
Read time: Less than a minute

Animal Origin Free (AOF) STEMxyme® collagenase/neutral protease (Dispase®) Blends 1 and 2, produced by Worthington Biochemical Corporation, are now available for primary and stem cell isolation, regenerative medicine, biopharmaceutical and cell bioprocessing applications.

These new, specialized combinations of AOF Clostridium histolyticum collagenase and AOF Bacillus polymyxa neutral protease (Dispase®) offer a minimum of 250 CLS units and 1,000 or 2,000 caseinase units per mg dry weight, respectively.

Produced at Worthington's ISO9001 Certified site, the blends are valuable in applications in which the potential for introduction of animal derived pathogens must be prevented and are available in research-scale to bulk-bioprocessing quantities.

Related Topic Pages
Infectious Diseases
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter